172,000.00
-1,000.00
(-0.58%)
At close: January 24 at 3:30:17 PM GMT+9
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
208,221,057.12
192,668,515.62
177,335,410.01
167,274,903.87
166,862,333.79
Cost of Revenue
109,518,225.08
95,702,222.19
87,340,758.05
84,196,690.19
72,862,414.44
Gross Profit
98,702,832.04
96,966,293.43
89,994,651.96
83,078,213.68
93,999,919.35
Operating Expense
--
87,406,478.00
77,770,000.00
98,371,301.00
88,477,014.00
Operating Income
75,838,996.04
9,559,815.43
12,224,651.96
-15,293,087.32
5,522,905.35
Net Non Operating Interest Income Expense
2,906,328.77
210,992.22
-672,681.15
-461,230.60
992,584.43
Pretax Income
11,891,415.40
-4,548,519.77
8,919,524.09
-19,549,099.49
16,580,831.05
Tax Provision
1,112,711.51
-360,766.22
87,703.62
-9,188,213.04
9,085,845.10
Net Income Common Stockholders
5,110,185.93
-10,382,721.09
5,837,527.76
-16,555,159.16
-965,677.31
Basic EPS
238.71
-463.00
265.00
-750.00
-45.00
Diluted EPS
238.71
-463.00
265.00
-750.00
-45.00
Basic Average Shares
23,257.47
22,424.88
22,028.41
22,073.55
21,459.50
Diluted Average Shares
23,257.47
--
--
22,073.55
21,459.50
Total Operating Income as Reported
5,271,629.09
9,559,814.33
12,224,651.49
-15,293,087.30
5,522,905.19
Rent Expense Supplemental
--
88,714.00
58,051.00
56,860.00
61,518.00
Total Expenses
132,382,061.08
183,108,700.19
165,110,758.05
182,567,991.19
161,339,428.44
Net Income from Continuing & Discontinued Operation
5,110,185.93
-10,382,721.09
5,837,527.76
-16,555,159.16
-965,677.31
Normalized Income
3,076,478.44
2,670,486.36
9,482,241.25
-13,318,069.91
-10,223,631.56
Interest Income
--
2,788,057.00
2,120,621.00
1,435,326.00
1,630,997.00
Interest Expense
--
2,577,066.00
2,793,303.00
1,896,557.00
638,413.00
Net Interest Income
2,906,328.77
210,992.22
-672,681.15
-461,230.60
992,584.43
EBIT
78,667,135.40
-1,971,453.77
11,712,827.09
-17,652,542.49
17,219,244.05
EBITDA
78,667,135.40
6,458,980.05
19,363,697.73
-10,911,988.70
23,904,574.85
Reconciled Cost of Revenue
109,518,225.08
95,702,222.19
87,340,758.05
84,196,690.19
72,862,414.44
Reconciled Depreciation
--
8,430,433.82
7,650,870.64
6,740,553.79
6,685,330.80
Net Income from Continuing Operation Net Minority Interest
5,110,185.93
-10,382,721.09
5,837,527.76
-16,555,159.16
-965,677.31
Total Unusual Items Excluding Goodwill
2,243,652.00
-14,177,714.00
-3,680,907.00
-4,316,119.00
12,343,939.00
Total Unusual Items
2,243,652.00
-14,177,714.00
-3,680,907.00
-4,316,119.00
12,343,939.00
Normalized EBITDA
76,423,483.40
20,636,694.05
23,044,604.73
-6,595,869.70
11,560,635.85
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
209,944.51
-1,124,506.55
-36,193.51
-1,079,029.75
3,085,984.75
12/31/2020 - 9/11/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4887.T Sawai Group Holdings Co., Ltd.
2,027.00
+0.67%
4540.T Tsumura & Co.
4,528.00
+0.33%
600079.SS HUMANWELL HEALTHCARE
21.89
-0.27%
600085.SS TONGRENTANG
36.75
+0.14%
4530.T Hisamitsu Pharmaceutical Co., Inc.
4,642.00
+0.04%
4521.T Kaken Pharmaceutical Co., Ltd.
4,292.00
+1.35%
000963.SZ Huadong Medicine Co., Ltd
34.11
-0.93%
ALKEM.BO Alkem Laboratories Limited
5,026.80
-2.95%
000999.SZ China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
44.18
+0.61%
002001.SZ Zhejiang NHU Company Ltd.
22.49
+0.40%